The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%>>>>

Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 260+ page report, which features 60+ figures and 110+ tables, please visit this link
Key Market Insights 
  • Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees.
  • The market landscape features the presence of well- established players in the domain, most of which claim to operate at various scales of operation and are located in different geographies.
  • In order to acquire competencies across the supply chain and cater to the evolving needs of clients, companies offering services across different scales of operation have established presence in various geographies.
  • Fill / finish service providers are actively investing in expansion projects to upgrade existing capabilities and capacity; several partnerships, mostly focused on offering contract services, have also been forged.
  • As expected, majority of the installed contract fill / finish capacity for prefilled syringes belongs to the large service providers, accounting for around 80% of the available global capacity.
  • The demand for fill / finish services for prefilled syringes is likely to steadily increase in the coming years; we believe stakeholders may have to expand their respective capacities to ensure a consistent supply.
  • An evaluation of prefilled syringe combination product developers revealed that Europe and North America have emerged as the key regions for partnering opportunities for fill / finish service providers.
  • Caste Study: Around 70 prefilled syringes are being manufactured by large companies, most of  which claim to be capable of fabricating syringe barrels from both glass and plastic materials.
  • We expect drug developers to continue to outsource their fill / finish operations in the short to mid term, resulting in an annualized growth at the rate of over 8% within the contract services market.
  • In the long-term, the projected opportunity for the fill / finish service providers for prefilled syringes is likely to be well distributed across various types of barrel chambers, scales of operation and geographical regions.
For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html
 
Table of Contents
 
1.         PREFACE
1.1.       Chapter Overview
1.2.       Scope of the Report
1.3.       Research Methodology
1.4.       Chapter Outlines

2.         EXECUTIVE SUMMARY
3.         INTRODUCTION
3.1.       Chapter Overview
3.2.       Introduction to Prefilled Syringes
3.2.1.    Classification of Prefilled Syringes
3.2.2.    Manufacturing of Prefilled Syringes
3.2.3.    Advantages of Prefilled Syringes
3.2.3.1. Benefits to Healthcare Professionals and End Users
3.2.3.2. Benefits to Manufacturers
3.3.       Fill / Finish Processing of Prefilled Syringes
3.3.1.    Steps Involved in Fill / Finish Process
3.3.2.    Methods of Filling and Stoppering of Prefilled Syringes
3.3.3.    Prefilled Syringe Filling Technologies
3.4.       Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market
3.5.       Need for Outsourcing Fill / Finish Operations of Sterile Injectables
3.6.       Advantages of Outsourcing Fill / Finish Services
3.7.       Risks Associated with Outsourcing of Fill / Finish Operations
3.8.       Key Considerations While Selecting a Fill / Finish Service Provider
4.         MARKET LANDSCAPE
4.1.       Chapter Overview
4.2.       Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape
4.2.1.    Analysis by Year of Establishment
4.2.2.    Analysis by Company Size
4.2.3.    Analysis by Scale of Operation
4.2.4.    Analysis by Location of Headquarters
4.2.5.    Analysis by Location of Prefilled Syringe Fill / Finish  Facilities
4.2.6.    Analysis by Type of Drug Molecule
4.2.7.    Analysis by Syringe Barrel Material
4.2.8.    Analysis by Syringe Fill Volume
4.2.9.    Analysis by Additional Services Offered
4.2.10.  Heat Map: Analysis by Company Size and Location of Headquarters
4.2.11.  Logo Landscape: Analysis by Company Size and Type of Drug Molecule
4.2.12.  Geographical Map: Analysis by Scale of Operation and Location of Fill / Finish Facilities
4.2.13.  Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
5.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
5.1.       Chapter Overview
5.2.       Ajinomoto Bio-Pharma Services
5.2.1.    Company  Overview
5.2.2.    Recent Developments and Future Outlook
5.3.       AMRI
5.3.1.    Company  Overview
5.3.2.    Recent Developments and Future Outlook
5.4.       BioPharma Solutions
5.4.1.    Company  Overview
5.4.2.    Recent Developments and Future Outlook
5.5.       Emergent BioSolutions
5.5.1.    Company  Overview
5.5.2.    Recent Developments and Future Outlook
5.6.       Patheon (a  Thermo Fisher Scientific Company)
5.6.1.    Company  Overview
5.6.2.    Recent Developments and Future Outlook
6.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES
6.1.       Chapter Overview
6.2.       Consort Medical
6.2.1.    Company  Overview
6.2.2.    Recent Developments and Future Outlook
6.3.       EVER Pharma
6.3.1.    Company  Overview
6.3.2.    Recent Developments and Future Outlook
6.4.       GlaxoSmithKline
6.4.1.    Company  Overview
6.4.2.    Recent Developments and Future Outlook
6.5.       IDT Biologika
6.5.1.    Company  Overview
6.5.2.    Recent Developments and Future Outlook
6.6.       Rentschler Biopharma
6.6.1.    Company  Overview
6.6.2.    Recent Developments and Future Outlook
6.7.       Siegfried
6.7.1.    Company  Overview
6.7.2.    Recent Developments and Future Outlook
6.8.       Vetter Pharma
6.8.1.    Company  Overview
6.8.2.    Recent Developments and Future Outlook
7.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
7.1.       Chapter Overview
7.2.       Biocon
7.2.1.    Company  Overview
7.2.2.    Recent Developments and Future Outlook
7.3.       Intas Pharmaceuticals
7.3.1.    Company  Overview
7.3.2.    Recent Developments and Future Outlook
7.4.       Kemwell Biopharma
7.4.1.    Company  Overview
7.4.2.    Recent Developments and Future Outlook
7.5.       Square Pharmaceuticals
7.5.1.    Company  Overview
7.5.2.    Recent Developments and Future Outlook
8.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS
8.1.       Chapter Overview
8.2.       List of Expansions
8.2.1.    Analysis by Year of Expansion
8.2.2.    Analysis by Type of Expansion
8.2.3.    Analysis by Expanded Scale of Operation
8.2.4.    Analysis by Location of Expansion Project
8.2.5.    Analysis by Type of Drug Molecule Involved
8.2.6.    Analysis by Additional Services Offered (Expansion Specific)
8.3.       Partnership Models
8.4.       List of Partnerships and Collaborations
8.4.1.    Analysis by Year of Partnership
8.4.2.    Analysis by Type of Partnership
8.4.3.    Analysis by Scale of Operation (Deal Specific)
8.4.4.    Analysis by Additional Services Offered (Deal Specific)
9.         CAPACITY ANALYSIS
9.1.       Chapter Overview
9.2.       Assumptions and Methodology
9.3.       Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)
9.3.1.    Analysis by Company Size
9.3.2.    Analysis by Scale of Operation
9.3.3.    Analysis by Location of Headquarters
9.3.4.    Analysis by Location of Fill / Finish Facilities
9.3.5.    Analysis by Type of Drug Molecule
9.4.       Global, Prefilled Syringe Fill / Finish Capacity (by Volume)
9.4.1.    Analysis by Company Size (Manufacturer)
9.4.2.    Analysis by Scale of Operation
9.4.3.    Analysis by Location of Headquarters
9.4.4.    Analysis by Location of Fill / Finish Facilities
9.4.5.    Analysis by Type of Drug Molecule
10.        DEMAND ANALYSIS
10.1.     Chapter Overview
10.2.     Assumptions and Methodology
10.3.     Global Demand for Prefilled Syringes Fill / Finish Services
10.3.1.  Global Demand for Commercialized Prefilled Syringes Fill / Finish Services
10.3.1.1. Analysis by Geography
10.3.1.1.1. North America
10.3.1.1.2. Europe
10.3.1.1.3. Asia-Pacific
10.3.1.1.4. Latin America
10.3.1.1.5. Middle East and Africa
10.3.1.2. Analysis by Syringe Barrel Material
10.3.1.3. Analysis by Number of Barrel Chambers
10.3.1.4. Analysis by Type of Drug Molecule
10.3.1.5. Analysis by Therapeutic Area
10.3.1.6. Analysis by Specialty Syringes
10.3.2.  Global Demand for Clinical Prefilled Syringes Fill / Finish Services
10.4.     Demand and Supply Analysis
10.4.1.  Demand and Supply Analysis (Scenario 1)
10.4.2.  Demand and Supply Analysis (Scenario 2)
10.4.3.  Demand and Supply Analysis (Scenario 3)
11.        GEOGRAPHICAL ASSESSMENT OF DEMAND AND SUPPLY
11.1.     Chapter Overview
11.2.     Assumptions and Key Parameters
11.3.     Demand and Supply Assessment in North America
11.3.1.  Key Geographies
11.3.1.1. US
11.4.     Demand and Supply Assessment in Europe
11.4.1.  Key Geographies
11.4.1.1. France
11.4.1.2. Germany
11.4.1.3. Italy
11.5.     Demand and Supply Assessment in Asia-Pacific Region
11.5.1.  Key Geographies
11.5.1.1. India
11.5.1.2. Japan
12.        LIKELY PARTNER ANALYSIS
12.1.     Chapter Overview
12.2.     Methodology and Key Parameters
12.3.     Likely Partner Analysis
12.3.1.  Opportunities in North America
12.3.1.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.1.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.2.  Opportunities in Europe
12.3.2.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.2.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.3.  Opportunities in Asia-Pacific and Rest of the World
12.3.3.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.3.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
13.        MARKET SIZING AND OPPORTUNITY ANALYSIS
13.1.     Chapter Overview
13.2.     Forecast Methodology and Key Assumptions
13.3.     Overall Prefilled Syringe Fill / Finish Services Market, 2020-2030
13.3.1.  Prefilled Syringe Fill / Finish Services Market: Distribution by Scale of Operation, 2020-2030
13.3.2.  Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Region
13.3.2.1. Prefilled Syringe Fill / Finish Services Market in North America
13.3.2.2. Prefilled Syringe Fill / Finish Services Market in Europe
13.3.2.3. Prefilled Syringe Fill / Finish Services Market in Asia-Pacific
13.3.2.4. Prefilled Syringe Fill / Finish Services Market Latin America
13.3.2.5. Prefilled Syringe Fill / Finish Services Market in Middle East and Africa
13.3.3.  Prefilled Syringe Fill / Finish Services Market: Distribution by Type of Drug Molecule, 2020-2030
13.3.4.  Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area
13.3.5.  Prefilled Syringe Fill / Finish Services Market: Distribution by Syringe Barrel Material, 2020-2030
13.3.6.  Prefilled Syringe Fill / Finish Services Market: Distribution by Number of Barrel Chambers, 2020-2030
14.        FUTURE GROWTH OPPORTUNITIES
14.1.     Chapter Overview
14.2.     Growing Injectable Drugs Pipeline
14.3.     Increase in Popularity of Prefilled Syringes
14.4.     Rise in Preference for Outsourcing Fill / Finish Activities
14.5.     Advances in Aseptic Fill / Finish Technologies
14.6.     Growing Opportunities in the Asia-Pacific Region
15.        CASE STUDY: PREFILLED SYRINGE MANUFACTURERS
15.1.     Chapter Overview
15.2.     Prefilled Syringes: List of Available / Under Development Devices
15.2.1.  Analysis by Syringe Barrel Material
15.2.2.  Analysis by Number of Barrel Chambers
15.2.3.  Analysis by Type of Needle System
15.2.4.  Analysis by Barrel Volume
15.3.     Prefilled Syringes: List of Manufacturers
15.3.1.  Analysis by Year of Establishment
15.3.2.  Analysis by Location of Headquarters
16.        CONCLUDING REMARKS
16.1.     Chapter Overview
16.2.     Key Takeaways
17.        INTERVIEW TRANSCRIPTS
17.1.     Chapter Overview
17.2.     Bio Elpida
17.2.1.  Company Snapshot
17.2.2.  Interview Transcript: Gilles Devillers, President and Cofounder
17.3.     Intas Pharmaceuticals
17.3.1.  Company Snapshot
17.3.2.  Interview Transcript: Kirti Maheshwari, Chief Technical Officer
17.4.     IDT Biologika
17.4.1.  Company Snapshot
17.4.2.  Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
17.5.     Takeda
17.5.1.  Company Snapshot
17.5.2.  Interview Transcript: Michael Dekner, Associate Director, Head of Process Sciences Formulation and Fill / Finish
17.6.     Synegene
17.6.1.  Company Snapshot
17.6.2.  Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development
17.7.     IDEO
17.7.1.  Company Snapshot
17.7.2.  Interview Transcript: Jesse Fourt, Design Director
18.        APPENDIX 1: TABULATED DATA
19.        APPENDIX 2: LIST OF COMPANIES
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
1153 Posts

Made with by Mamby